NEW YORK (GenomeWeb) – Food safety test developer Roka Bioscience announced today that it has signed an agreement to privately sell roughly 22,500 shares of preferred stock for $22.5 million.

According to the company, each share of the Series A preferred stock is convertible into approximately 1,428 shares of common stock, which is equivalent to a purchase price of $.70 per common share. For each preferred share, Roka said, purchasers will receive a five-year warrant to buy about 1,428 shares of common stock at $.70 per share.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.